4I31

Crystal structure of HCV NS3/NS4A protease complexed with compound 4


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.9301 Å
  • R-Value Free: 0.247 
  • R-Value Work: 0.216 

wwPDB Validation 3D Report Full Report


This is version 1.2 of the entry. See complete history

Literature

Molecular Mechanism by Which a Potent Hepatitis C Virus NS3-NS4A Protease Inhibitor Overcomes Emergence of Resistance.

O'Meara, J.A.Lemke, C.T.Godbout, C.Kukolj, G.Lagace, L.Moreau, B.Thibeault, D.White, P.W.Llinas-Brunet, M.

(2013) J.Biol.Chem. 288: 5673-5681

  • DOI: 10.1074/jbc.M112.439455
  • Primary Citation of Related Structures:  4I32, 4I33

  • PubMed Abstract: 
  • Although optimizing the resistance profile of an inhibitor can be challenging, it is potentially important for improving the long term effectiveness of antiviral therapy. This work describes our rational approach toward the identification of a macroc ...

    Although optimizing the resistance profile of an inhibitor can be challenging, it is potentially important for improving the long term effectiveness of antiviral therapy. This work describes our rational approach toward the identification of a macrocyclic acylsulfonamide that is a potent inhibitor of the NS3-NS4A proteases of all hepatitis C virus genotypes and of a panel of genotype 1-resistant variants. The enhanced potency of this compound versus variants D168V and R155K facilitated x-ray determination of the inhibitor-variant complexes. In turn, these structural studies revealed a complex molecular basis of resistance and rationalized how such compounds are able to circumvent these mechanisms.


    Organizational Affiliation

    Boehringer Ingelheim (Canada) Limited, Research and Development, Laval, Quebec H7S 2G5, Canada. RESGeneral.lav@boehringer-ingelheim.com




Macromolecules

Find similar proteins by: Sequence  |  Structure

Entity ID: 1
MoleculeChainsSequence LengthOrganismDetails
Genome polyprotein
A, B
187Hepatitis C virus genotype 1bEC: 3.6.1.15, 3.4.22.-, 3.6.4.13, 2.7.7.48, 3.4.21.98
Find proteins for P26662 (Hepatitis C virus genotype 1b)
Go to UniProtKB:  P26662
Entity ID: 2
MoleculeChainsSequence LengthOrganismDetails
HCV non-structural protein 4A
C, D
17Hepatitis C virus genotype 1bEC: 3.6.1.15, 3.4.22.-, 3.6.4.13, 2.7.7.48, 3.4.21.98
Find proteins for P26662 (Hepatitis C virus genotype 1b)
Go to UniProtKB:  P26662
Small Molecules
Ligands 2 Unique
IDChainsName / Formula / InChI Key2D Diagram3D Interactions
NA
Query on NA

Download SDF File 
Download CCD File 
A, B
SODIUM ION
Na
FKNQFGJONOIPTF-UHFFFAOYSA-N
 Ligand Interaction
1BV
Query on 1BV

Download SDF File 
Download CCD File 
A, B
(2R,6S,7E,10E,13aR,14aR,16aS)-2-{[7-methoxy-8-methyl-2-(propan-2-yloxy)quinolin-4-yl]oxy}-N-[(1-methylcyclopropyl)sulfonyl]-6-{[(1-methyl-1H-pyrazol-3-yl)carbonyl]amino}-5,16-dioxo-1,2,3,6,9,12,13,13a,14,15,16,16a-dodecahydrocyclopropa[e]pyrrolo[1,2-a][1,4]diazacyclopentadecine-14a(5H)-carboxamide
C41 H51 N7 O9 S
ZHIQOLBHZJFLCW-QVARATBXSA-N
 Ligand Interaction
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.9301 Å
  • R-Value Free: 0.247 
  • R-Value Work: 0.216 
  • Space Group: P 61
Unit Cell:
Length (Å)Angle (°)
a = 94.243α = 90.00
b = 94.243β = 90.00
c = 82.075γ = 120.00
Software Package:
Software NamePurpose
d*TREKdata reduction
PHENIXrefinement
PHENIXmodel building
MAR345dtbdata collection
d*TREKdata scaling
PHENIXphasing

Structure Validation

View Full Validation Report or Ramachandran Plots



Entry History 

Deposition Data

  • Deposited Date: 2012-11-23 
  • Released Date: 2013-01-02 
  • Deposition Author(s): Lemke, C.T.

Revision History 

  • Version 1.0: 2013-01-02
    Type: Initial release
  • Version 1.1: 2013-01-09
    Type: Database references
  • Version 1.2: 2013-03-13
    Type: Database references